D-0314-2021 Class III Terminated

Recalled by Cardinal Health Inc. — Dublin, OH

FDA drug recall D-0314-2021 was initiated by Cardinal Health Inc. on Mar 9, 2021 and is designated Class III. Reason for recall: Temperature Abuse The recall status is terminated (terminated Nov 4, 2021). Affected quantity: 48 boxes.

Recall details

Product Type
Drugs
Report Date
Apr 7, 2021
Initiation Date
Mar 9, 2021
Termination Date
Nov 4, 2021
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
48 boxes

Product description

Tremfya (guselkumab) Injection, 100 mg/mL, one single-dose prefilled syringe per carton, Rx only, Manufactured by: Janssen Biotech, Inc., Horsham, PA 19044; NDC 57894-640-01.

Reason for recall

Temperature Abuse

Distribution pattern

AL, LA, MS, TN

Code information

KESOY.AI Exp. 04/2022

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-0314-2021
openFDA file date
Nov 10, 2026
Loaded by RegDataLab
Nov 11, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-0314-2021. Report a data issue: hello@regdatalab.com.